iBio, Inc.
(NYSE Amex Equities : IBIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. -0.21%239.821.3%$789.32m
MRNAModerna, Inc. 4.67%68.210.0%$720.49m
IMMUImmunomedics, Inc. -0.07%85.2411.0%$688.66m
NVAXNovavax, Inc. 10.16%112.8596.5%$617.36m
GILDGilead Sciences, Inc. -0.54%61.921.0%$571.92m
ILMNIllumina, Inc. 3.77%297.123.5%$521.91m
REGNRegeneron Pharmaceuticals, Inc. 1.26%564.462.7%$430.41m
BIIBBiogen, Inc. -0.23%269.431.6%$332.40m
VRTXVertex Pharmaceuticals, Inc. 0.07%263.321.9%$328.48m
ALXNAlexion Pharmaceuticals, Inc. 0.62%112.712.0%$279.95m
SRNESorrento Therapeutics, Inc. 3.58%9.521.5%$255.20m
EXASEXACT Sciences Corp. 3.98%98.0620.7%$241.27m
VXRTVaxart, Inc. 5.88%7.300.0%$210.40m
SGENSeattle Genetics, Inc. 1.43%181.996.0%$206.78m
MNTAMomenta Pharmaceuticals, Inc. 0.03%52.413.0%$197.92m

Company Profile

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.